NPC 349
Latest Information Update: 14 Nov 1994
Price :
$50 *
At a glance
- Originator Scios
- Class Antihypertensives; Kinins; Neuropeptides; Oligopeptides
- Mechanism of Action Bradykinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma